Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

Abstract

These findings suggest that increased hepcidin across the spectrum of CKD may contribute to abnormal iron regulation and erythropoiesis and may be a novel biomarker of iron status and erythropoietin resistance.